Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance [Yahoo! Finance]
Certara, Inc. (CERT)
Company Research
Source: Yahoo! Finance
Certara FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj. EBITDA of $32.5M (-3% decline) FY 2026 Revenue Growth of 0-4% FY 2026 Adjusted EBITDA Margin of 30-32% FY 2026 Adjusted Diluted EPS of $0.44-$0.48 RADNOR, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its fourth quarter and full fiscal year 2025 financial results. Fourth Quarter Highlights: Appointment of Jon Resnick as Chief Executive Officer and Member of the Board of Directors, effective January 1st, 2026. Revenue was $103.6 million, compared to $100.4 million in the fourth quarter of 2024, representing growth of 3%. Software revenue was $46.4 million, compared to $42.3 million in the fourth quarter of 2024, representing growth of 10%. Services revenue was $57.3 million, compared to $58.1 million in the fourth quarter of 2024, repr
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara (CERT) had its "equal weight" rating reaffirmed by Barclays PLC. They now have a $8.00 price target on the stock.MarketBeat
- Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib [Yahoo! Finance]Yahoo! Finance
- Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminibGlobeNewswire
- Assessing Certara (CERT) Valuation After Recent Share Price Volatility [Yahoo! Finance]Yahoo! Finance
- Certara (CERT) had its price target lowered by Barclays PLC from $13.00 to $8.00. They now have an "overweight" rating on the stock.MarketBeat
CERT
Earnings
- 2/26/26 - Beat
CERT
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 3
- 2/26/26 - Form 10-K
- CERT's page on the SEC website